• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄酮类化合物通过一种不依赖于 HIF-1 的机制抑制低氧诱导的血管内皮生长因子表达。

Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism.

机构信息

Department of Biochemistry and Molecular Biology, University of Navarra, Pamplona, Spain.

出版信息

Biochem Pharmacol. 2010 Jun 1;79(11):1600-9. doi: 10.1016/j.bcp.2010.02.004. Epub 2010 Feb 11.

DOI:10.1016/j.bcp.2010.02.004
PMID:20153296
Abstract

Flavonoids are a group of polyphenolic dietary compounds that have been proposed to possess chemopreventive properties against lung cancer. In this work we analyzed the effect of a group of 20 structurally related flavonoids, including flavones, flavonols and isoflavones, on the production of vascular endothelial growth factor (VEGF) induced by hypoxia in NCI-H157 cells. VEGF is the main regulator of physiological and pathological angiogenesis and is highly stimulated by hypoxia-inducible factor 1 (HIF-1). We found that apigenin, luteolin, fisetin and quercetin inhibited hypoxia-induced VEGF expression in the low micromolar range. Structure-activity relationships demonstrated that flavone derivatives were the most active compounds and that hydroxylation of the A ring at the positions 5 and 7 and of the B ring at the 4' position were important for this activity. Interestingly, only a group of VEGF inhibitors, including apigenin, flavone and 4',7-dihydroxiflavone, reduced the expression of HIF-1alpha under these conditions, whereas others, such as fisetin, luteolin, galangin or quercetin, induced HIF-1alpha expression while reducing those of VEGF. When cells were exposed to hypoxia in the presence of these flavonoids, HIF-1alpha translocated to the nucleus and interacted with p300/CBP, but this complex was transcriptionally inactive. Taken together these findings indicate that flavonoids impair VEGF transcription by an alternative mechanism that did not depend on nuclear HIF levels. We also found that flavonoids suppressed hypoxia-induced STAT3 tyrosine phosphorylation and that this activity correlated with their potency as VEGF inhibitors, suggesting that inhibition of STAT3 function may play a role in this process.

摘要

类黄酮是一组多酚类膳食化合物,据推测具有预防肺癌的化学预防特性。在这项工作中,我们分析了一组 20 种结构相关的类黄酮(包括黄酮、黄酮醇和异黄酮)对 NCI-H157 细胞缺氧诱导的血管内皮生长因子(VEGF)产生的影响。VEGF 是生理和病理血管生成的主要调节剂,高度受缺氧诱导因子 1(HIF-1)刺激。我们发现,芹菜素、木樨草素、非瑟酮和槲皮素以低微摩尔范围抑制缺氧诱导的 VEGF 表达。结构-活性关系表明,黄酮衍生物是最活跃的化合物,A 环在 5 和 7 位以及 B 环在 4'位的羟基化对这种活性很重要。有趣的是,只有一组 VEGF 抑制剂,包括芹菜素、黄酮和 4',7-二羟基黄酮,在这些条件下降低 HIF-1α的表达,而其他如非瑟酮、木樨草素、姜黄素或槲皮素,在降低 VEGF 表达的同时诱导 HIF-1α的表达。当细胞在这些类黄酮存在下暴露于缺氧时,HIF-1α易位到核内并与 p300/CBP 相互作用,但这种复合物转录失活。这些发现表明,类黄酮通过不依赖核 HIF 水平的替代机制损害 VEGF 转录。我们还发现,类黄酮抑制缺氧诱导的 STAT3 酪氨酸磷酸化,并且这种活性与它们作为 VEGF 抑制剂的效力相关,表明抑制 STAT3 功能可能在这个过程中发挥作用。

相似文献

1
Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism.黄酮类化合物通过一种不依赖于 HIF-1 的机制抑制低氧诱导的血管内皮生长因子表达。
Biochem Pharmacol. 2010 Jun 1;79(11):1600-9. doi: 10.1016/j.bcp.2010.02.004. Epub 2010 Feb 11.
2
Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.化学预防生物类黄酮芹菜素对人前列腺癌PC3-M细胞中HIF-1α和VEGF表达的抑制作用伴随着Akt的抑制。
Mol Carcinog. 2008 Sep;47(9):686-700. doi: 10.1002/mc.20421.
3
Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells.咖啡酸及其合成衍生物CADPE通过阻断人肾癌细胞中STAT3介导的VEGF表达来抑制肿瘤血管生成。
Carcinogenesis. 2007 Aug;28(8):1780-7. doi: 10.1093/carcin/bgm130. Epub 2007 Jun 8.
4
Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation.类黄酮通过抑制核因子κB激活来预防细胞因子诱导的胰腺β细胞损伤。
Pancreas. 2007 Nov;35(4):e1-9. doi: 10.1097/mpa.0b013e31811ed0d2.
5
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.缺氧诱导因子-1α(HIF-1α)、信号转导和转录激活因子3(STAT3)、CREB结合蛋白/ p300(CBP/p300)以及氧化还原因子-1/脱嘌呤嘧啶核酸内切酶(Ref-1/APE)是一种转录复合物的组成成分,该复合物可调节Src依赖的缺氧诱导的胰腺癌和前列腺癌中血管内皮生长因子(VEGF)的表达。
Oncogene. 2005 Apr 28;24(19):3110-20. doi: 10.1038/sj.onc.1208513.
6
The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF.抗氧化剂槲皮素通过 HIF-1 依赖性诱导 p21WAF 来抑制细胞增殖。
Antioxid Redox Signal. 2010 Aug 15;13(4):437-48. doi: 10.1089/ars.2009.3000.
7
Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.顺铂和阿霉素可抑制人卵巢癌细胞中血管内皮生长因子的表达,并差异性地下调缺氧诱导因子I的活性。
Biochem Pharmacol. 2007 Jul 15;74(2):191-201. doi: 10.1016/j.bcp.2007.04.003. Epub 2007 Apr 6.
8
Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.拓扑替康可阻断胰岛素样生长因子-I在神经母细胞瘤细胞中诱导的缺氧诱导因子-1α和血管内皮生长因子的表达。
Cancer Res. 2005 Jun 1;65(11):4775-81. doi: 10.1158/0008-5472.CAN-04-3332.
9
Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.黄酮类化合物通过激活蛋白-1和核因子-κB抑制肿瘤坏死因子-α诱导的呼吸道上皮细胞细胞间黏附分子-1(ICAM-1)上调:构效关系
Mol Pharmacol. 2004 Sep;66(3):683-93. doi: 10.1124/mol.66.3..
10
Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer.芹菜素抑制人肺癌细胞中血管内皮生长因子的表达及血管生成:对肺癌化学预防的启示
Mol Pharmacol. 2005 Sep;68(3):635-43. doi: 10.1124/mol.105.011254. Epub 2005 Jun 9.

引用本文的文献

1
Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis.蜂胶中存在的类黄酮调节血管内皮生长因子信号传导以调控血管生成的潜在治疗作用。
Phytother Res. 2025 Sep;39(9):4230-4246. doi: 10.1002/ptr.70029. Epub 2025 Aug 9.
2
The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer.植物源天然产物作为酪氨酸激酶途径调节剂在肺癌治疗中的作用
Curr Issues Mol Biol. 2025 Jun 30;47(7):498. doi: 10.3390/cimb47070498.
3
Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks.
基于顺铂的脂质体纳米载体在肺癌治疗中的药物递送:最新进展和未来展望。
Curr Pharm Des. 2024;30(36):2850-2881. doi: 10.2174/0113816128304923240704113319.
4
Flavonoids with Anti-Angiogenesis Function in Cancer.具有抗肿瘤血管生成功能的类黄酮。
Molecules. 2024 Mar 31;29(7):1570. doi: 10.3390/molecules29071570.
5
The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.异黄酮作为肺癌化学预防剂的应用及其在放射增敏治疗中的意义。
Curr Med Chem. 2025;32(2):214-237. doi: 10.2174/0109298673278897231229121524.
6
Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells.JZL184 通过抑制低氧肺癌细胞中 VEGF 的表达对内皮细胞发挥抗血管生成作用。
Cells. 2023 Sep 22;12(19):2332. doi: 10.3390/cells12192332.
7
Hypobaric hypoxia induced renal injury in rats: Prophylactic amelioration by quercetin supplementation.低压缺氧诱导大鼠肾损伤:槲皮素补充的预防改善作用。
PLoS One. 2023 Feb 24;18(2):e0279304. doi: 10.1371/journal.pone.0279304. eCollection 2023.
8
Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.抑制 HIF-1 生存通路作为增强光动力疗法疗效的策略。
Methods Mol Biol. 2022;2451:285-403. doi: 10.1007/978-1-0716-2099-1_19.
9
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design.非小细胞肺癌中的循环肿瘤细胞(CTCs):从预后到治疗设计
Pharmaceutics. 2021 Nov 5;13(11):1879. doi: 10.3390/pharmaceutics13111879.
10
HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases.HIF-1α 是草药治疗疾病的潜在分子靶标。
Drug Des Devel Ther. 2020 Nov 16;14:4915-4949. doi: 10.2147/DDDT.S274980. eCollection 2020.